TRIAL DETAIL
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Completed |
|||
Phase: |
3 |
Start Date 03/01/2018 |
Age of Trial (yrs) 6.2 |
|
Treatment Phase: |
Management |
|||
Drug Category: |
||||
Strategy: |
||||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
AMC1801 |
|||
Sponsor: |
Asan Medical Center |
|||
Patient Contact: |
Yoon-Koo Kang, MD, PhD
+82-2-3010-3230
ykkang@amc.seoul.kr |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
Randomized |
|||
IV or Oral: |
Oral |
|||
Trial Notes: |
Detailed Description: One of the most common side effects of imatinib treatment, muscle cramps occur in about 30% of patients with gastrointestinal stromal tumor (GIST) receiving treatment with imatinib. It affects the quality of life (QoL) of patients and could also be a factor that affects compliance with treatment. Some studies suggest that L-carnitine may improve muscle cramps associated with cirrhosis or hemodialysis. However, the efficacy of L-carnitine for muscle cramps occurring after imatinib treatment has yet to be reported. Thus, we aim to evaluate the efficacy of L-carnitine for the treatment of muscle cramps after imatinib in patients with GIST and apply in the future. |
|||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Seoul |
Songpa-gu |
138-736 |
Republic of Korea |